#Nifty near its weekly 108ema {15300) last time that was tested was back in Sept 2020 which then led to a very strong rally. For now, lets see if it holds and gives a bounce (reversal can be reviewed later)

Monthly 34ema is at 14600, if the weekly support fails to hold then this becomes the next major and super one to start aggressive buying near it
The immediate resistance is at daily 13ema currently at 16000 (will dip down). Only if Nifty breaks and sustains above it will I consider a bottom done, else will treat it just like a bounce in case it turns before testing the Monthly 34ema
The last leg of every correction is always severe, all you read/hear is utter chaos. From today start looking at stocks you would like to add to your portfolio for the MEDIUM/LONG term - we are almost there. Happy Investing!

More from Niftylongterm

#repost

You May Also Like

@EricTopol @NBA @StephenKissler @yhgrad B.1.1.7 reveals clearly that SARS-CoV-2 is reverting to its original pre-outbreak condition, i.e. adapted to transgenic hACE2 mice (either Baric's BALB/c ones or others used at WIV labs during chimeric bat coronavirus experiments aimed at developing a pan betacoronavirus vaccine)

@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice


@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2


@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj


@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o